from Reuters: Health News https://reut.rs/2GrhCSf
AstraZeneca's infant respiratory drug prioritised in Europe, U.S.
Britain's AstraZeneca said a potential medicine to prevent respiratory syncytial virus (RSV) in babies and infants had been granted special status by U.S. and European regulators, designed to speed up the development of novel and better drugs.
from Reuters: Health News https://reut.rs/2GrhCSf
from Reuters: Health News https://reut.rs/2GrhCSf
Subscribe to:
Post Comments (Atom)
-
The German cabinet will hold a secret session on Wednesday to discuss safeguard measures regarding the possible participation of China's...
-
Stocks poised for another day of gains Equity markets look to add to the gains from the prior session as investor concerns about the fu...
-
By LIAM STACK from NYT Magazine https://ift.tt/2FNPp6k
No comments:
Post a Comment